This undated image provided by researcher Canan Dagdeviren in January 2018 shows an implant that can precisely drip medications deep into the brain by remote control. The device could mark a new approach to treating brain diseases _ potentially reducing side effects by targeting only the…
News
- Tiny implant opens way to deliver drugs deep into the brain
- Scientists successfully clone monkeys; could humans be next?
Henry Greely, a Stanford University law professor who specializes in the implications of biomedical technologies, said the strongest argument he can think of would be the desire of grieving parents to produce a genetic duplicate of a dead child. But he doubts that's a compelling enough reason to…
- Johnson & Johnson loses $10.7B after sweeping US tax changes
The maker of biotech drugs and Band-Aids said the fourth-quarter loss amounts to $3.99 per share. A year earlier, the New Brunswick, New Jersey, company had a net profit of $3.81 billion, or $1.38 per share. Excluding the tax charge and other one-time gains and costs, earnings came to $4.78…
- Markets Right Now: More records for stocks, led by tech
French pharmaceutical company Sanofi and biotech drugmaker Celgene both announced large acquisitions. Investors don't seem to be fazed by the federal government shutdown as it entered its third day. The Standard & Poor's 500 index rose 8 points, or 0.3 percent, to 2,818. The Dow Jones…
- Cytbioscience $21.82 million Fundraising. James R Garvin Filed Jan 22 Form D
Cytbioscience is based in Texas. The firm's business is Biotechnology. The SEC form was filed by James R Garvin CEO. The company was incorporated in 2014. The filler's address is: 3463 Magic Drive, Suite 120, San Antonio, Tx, Texas, 78229. James R. Garvin is the related person in the form and it…